MARIA LUBRANO-LOBIANCO: Open Payments
NPI 1336691435 · PHOENIXVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$364 in 7 payments from 5 companies in 2025. Trend: 2023 $772 · 2024 $79 · 2025 $364
Food & beverage: $364
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $151 |
| Neurocrine BioSciences, Inc. | 1 | $136 |
| AstraZeneca Pharmaceuticals LP | 2 | $31 |
| AtriCure, Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $18 |
Products named: JARDIANCE, INGREZZA, FARXIGA, ATRICLIP LAA EXCLUSION SYSTEM, LEQVIO.
Industry payments across PA — which companies pay providers there.
